No abstract available
MeSH terms
-
Clinical Decision-Making
-
Fibrinolytic Agents* / adverse effects
-
Fibrinolytic Agents* / therapeutic use
-
Humans
-
Ischemic Stroke* / drug therapy
-
Risk Assessment
-
Risk Factors
-
Thrombolytic Therapy* / adverse effects
-
Treatment Outcome